The German Epidemiological Hemodialysis Itch Study (GEHIS): 10-year follow-up of pruritus and health-related quality of life in patients on haemodialysis

Chronic pruritus (CP) in patients on haemodialysis (HD) is a phenomenon that is difficult to control. While some drugs, such as difelikefalin, showed promising results in the reduction of CP, others failed. The German Epidemiological Hemodialysis Itch Study (GEHIS) is a representative, prospective cross-sectional observational cohort study of 860 patients on HD, which began in 2013. It addresses the prevalence and associated factors of CP, such as health-related quality of life, in patients on HD.